Last updated on March 26, 2020
The solution contains a Corona-Screen Kit – a transportable, light-weight equipment that features fundamental screening instruments that seamlessly join and feed knowledge right into a Patient Health Record (PHR) system with none handbook intervention.
It additionally has a geo-tagging powered screening app that can import and analyse knowledge from the screening instruments in addition to as journey and medical historical past. The enter from a 3rd get together COVID-19 speedy testing equipment additional enhances the accuracy of the end result. This can be marketed to the federal government and massive healthcare supply organisations to start out with, adopted by hospitals, in India and globally.
“Mass screening and testing is the necessity of the hour. With the shortage of healthcare professionals, there’s a want of know-how enabled platforms to do that at a big scale with minimal to no human intervention.
The ReMeDi SCAN-CORONA brings collectively distant healthcare experience and the ability of rising know-how comparable to AI & ML, and guarantees to cut back the load on the healthcare system, in order that well timed care reaches the suitable set of individuals as quick as potential,” mentioned Shree Shingane, Managing Director, e-Zest Solutions GmbH.
This would additionally assist healthcare suppliers remotely deal with non-corona well being necessities as properly, mentioned the corporate in a press launch.
“ReMeDi SCAN-CORONA helps front-line well being employees to shortly assess the important danger components for an individual digitally. It has the distinctive skill to trace the development of signs with time.
The Tele-consultation facility permits people to acquire counselling in addition to seek the advice of docs unbiased of location, to entry well timed data and steerage,” mentioned Sameer Sawarkar CEO -Neurosynaptic. E-Zest is an agile digital know-how agency, whereas Neurosynaptic Communications is a telemedicine and healthcare options supplier.